Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer
This clinical study reports that blood levels of the pro-inflammatory mediator platelet-activating factor (PAF) did not change in colorectal cancer patients. In contrast, plasma levels of two enzymatic activities, one implicated in PAF production (i.e. phospholipase A2) and one in PAF degradation (i...
Saved in:
Main Authors: | Yves Denizot, Véronique Truffinet, Stéphane Bouvier, Alain Gainant, Pierre Cubertafond, Muriel Mathonnet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350410001664824 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases
by: P. Vergne, et al.
Published: (1997-01-01) -
Expression of a splice variant of the platelet-activating
factor receptor transcript 2 in various human cancer cell lines
by: Ibtissam Youlyouz, et al.
Published: (2002-01-01) -
Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes
by: Annaleise V. Sampey, et al.
Published: (2000-01-01) -
Increasing the concentration of plasma molecules improves the biological activity of platelet-rich plasma for tissue regeneration
by: Mikel Sánchez, et al.
Published: (2025-02-01) -
Maintenance of Synaptic Stability Requires Calcium-Independent Phospholipase A2 Activity
by: Julie Allyson, et al.
Published: (2012-01-01)